| Myocardial energetics and clinical response to the cardiotonic agent MDL 17043 in advanced heart failure. | |
| | |
MedLine Citation:
|
PMID: 6238075 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Cardiotonic agents may prove useful in the long-term treatment of chronic heart failure provided myocardial efficiency is enhanced and clinical status is improved. Accordingly, the short-term hemodynamic and clinical response to the phosphodiesterase inhibitor, MDL 17043, was evaluated. Intravenous increments of 0.05 mg/kg (maximal total 3 mg/kg) were given to a peak cardiac output response in 13 patients with New York Heart Association functional class IV heart failure secondary to ischemic or myopathic disease. Significant (p less than 0.05) responses at peak effect (1.7 mg/kg) included an increase in cardiac output (3.5 to 4.6 liters/min) and heart rate (86 to 90 beats/min) and a decrease in pulmonary capillary wedge (25 to 17 mm Hg), mean arterial (85 to 78 mm Hg) and right atrial (10 to 7 mm Hg) pressures. Coronary sinus flow (measured in nine patients) increased (122 to 144 ml/min, p less than 0.01) as did myocardial oxygen uptake (14.1 to 15.1 ml/min, p less than 0.01), whereas myocardial extraction of oxygen (78 to 72%, p less than 0.01) and lactate (24 to 9%, p less than 0.01) decreased with three patients producing lactate at the time of their peak cardiac output response. Nine of the 12 patients given long-term oral therapy improved at least one functional class at 2 weeks. This improvement was sustained at 20 weeks in five patients. Thus, MDL 17043 acutely improves the function of the failing heart. However, the decrease in oxygen extraction occurring with increased myocardial oxygen uptake suggests that intracoronary shunting may occur along with an increase in oxygen demand and contribute to myocardial anaerobiosis in some patients.(ABSTRACT TRUNCATED AT 250 WORDS) |
| | |
Authors:
|
J L Martin; M J Likoff; J S Janicki; W K Laskey; J W Hirshfeld; K T Weber |
Related Documents
:
|
6127895 - Effect of intravenous prenalterol on haemodynamics and myocardial lactate extraction in... 7314085 - Myocardial oxygen extraction rate under general anesthesia. 2297835 - Effects of nitroprusside on myocardial blood flow and oxygen consumption in conscious l... 7864215 - Dichloroacetate stimulates carbohydrate metabolism but does not improve systolic functi... 10098245 - Heart rate variability. 17848765 - Biochemical markers of myocardial injury during coronary artery bypass grafting with an... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Journal of the American College of Cardiology Volume: 4 ISSN: 0735-1097 ISO Abbreviation: J. Am. Coll. Cardiol. Publication Date: 1984 Nov |
Date Detail:
|
Created Date: 1984-11-28 Completed Date: 1984-11-28 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8301365 Medline TA: J Am Coll Cardiol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 875-83 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Cardiac Output / drug effects Cardiotonic Agents / therapeutic use* Coronary Circulation / drug effects Enoximone Female Heart Failure / drug therapy*, metabolism, physiopathology Heart Rate / drug effects Hemodynamics / drug effects* Humans Imidazoles / metabolism, therapeutic use* Lactates / metabolism Male Middle Aged Myocardium / metabolism* Oxygen Consumption / drug effects Pulmonary Wedge Pressure / drug effects |
| Chemical | |
Reg. No./Substance:
|
0/Cardiotonic Agents; 0/Imidazoles; 0/Lactates; 77671-31-9/Enoximone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Dental sequelae to the binge-purge syndrome (bulimia): report of cases.
Next Document: Intravenous and oral MDL 17043 (a new inotrope-vasodilator agent) in congestive heart failure: hemod...